VIDAS D-Dimer Exclusion II 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Biomerieux 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2013-04-16
  • 사례 출판 날짜
    2013-04-16
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: biomerieux vidas d-dimer exclusion ii medical device manufacturer, biomerieux, has issued a field safety notice concerning the vidas d-dimer exclusion ii [reference no.: 30455 and 30455-01]. the manufacturer has registered some customer complaints about not reproducible results below the detection limit (<45 ng/ml) on the above listed lot numbers. the manufacturer’s internal investigation after testing in-house titrated samples has not reproduced this result. the potential risk associated to this issue is reporting false negative results for vidas d-dimer exclusion ii. the impact of a false negative d-dimer test result could be critical for the patient with a low or moderate clinical pretest probability for deep vein thrombosis (dvt) or pulmonary embolism (pe) because it could prevent further diagnostic workup for venous thromboembolism and withholding anticoagulant treatment when it is actually needed, resulting in a negative impact to patient care. the manufacturer advises all affected users to take the following actions:- repeat all results less than < 45 ng/ml obtained with the kit vidas® d-dimer exclusion ii™ ref. 30455 and 30455-01. determine if retrospective analysis of results of the patients is required and investigate further (e.G. final diagnosis and clinical status of the patient) if the result is < 45 ng/ml. an additional insert will be added to newly manufactured lots to require a confirmation of the results below the detection limit (< 45 ng/ml). according to the local supplier, the affected devices were distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 16 april 2013.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Biomerieux VIDAS D-Dimer Exclusion II
  • Manufacturer

Manufacturer